Skip to main content
. 2011 May 5;84(5):825–829. doi: 10.4269/ajtmh.2011.10-0699

Table 2.

Overall number of adverse events

Population Cohort 1 (mefloquine; N = 23) Cohort 2 (infectivity control; N = 6)
Total number of AEs 112 22
Total number of subjects with any AE 20 (87.0%) 6 (100.0%)
Total number of subjects with grade 1 AE 19 (82.6%) 6 (100.0%)
Total number of subjects with grade 2 AE 13 (56.5%) 4 (66.7%)
Total number of subjects with grade 3 AE 2 (8.7%) 0 (0.0%)